Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(17)30447-3
PubMed Identifier: 28784312
Publication URI: http://europepmc.org/abstract/MED/28784312
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Oncology
Issue: 9
ISSN: 1470-2045